Brussels   |     |   Members Only

Antibiotic resistance: Preventing a crisis


Seventy-five years ago, antibiotics were the wonder drugs of the age; today, they are the worry drugs. Through over-use, antibiotics have prompted many bacteria to develop resistance to them – so much so that, a UK review panel estimated, about 700,000 people a year die due antibiotic-resistant disease around the world. In response, we have made a little progress in controlling antibiotic overuse in farming; but the innovation pipeline of new antibiotics is worryingly small. At this rate, EU Health Commissioner Vytenis Andriukaitis recently warned, “we face a frightening future where routine surgery, childbirth, pneumonia and even skin infections could once again become life threatening.”

How do we get the R&D pipeline flowing faster? What programmes, policies and strategies could the EU now adopt? This Science|Business dinner debate will gather latest information on the problem, and brainstorm for new solutions.

The event will take place on 10 April 2018, from 18:30 to 21:00.

For more details, please contact Lysiane Pons at lysiane.pons@sciencebusiness.net

Featured Guests
Speakers
Xavier Prats Monné
Director General, DG Health and Food Safety, European Commission
Karin Kadenbach
Member, European Parliament
Lieve Wierinck
Belgian Member, European Parliament; Shadow Rapporteur, ITRE Committee
Johan Van Eldere
Chief Physician, University Hospital UZ Leuven
Patrick Holmes
Head, International Policy, Pfizer Global Policy and International Public Affairs
Line Matthiessen
Acting Director, Directorate for Health, DG Research and Innovation, European Commission